Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 328 entries
View as:

S1204, Viral Screening in Newly Diagnosed Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01946516 Org: User:
Start: 08/29/13 End: 10/13/22 Due: 10/13/23

S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil

Phase: N/A Priority: Normal
NCT ID: NCT00897091 Org: User:
Start: 07/31/06 End: 10/31/07 Due: 10/31/08

S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02137837 Org: User:
Start: 05/31/14 End: 12/31/19 Due: 12/31/20

S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00062439 Org: User:
Start: 07/31/03 End: 12/31/10 Due: 12/31/11

S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01338974 Org: User:
Start: 03/31/11 End: 08/31/12 Due: 08/31/13

Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT04205955 Org: User:
Start: 02/10/20 End: 08/01/23 Due: 08/01/24

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT07018869 Org: User:
Start: 10/21/25 End: 03/23/29 Due: 03/23/30

S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00376961 Org: User:
Start: 08/31/06 End: 09/30/17 Due: 09/30/18

S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium

Phase: N/A Priority: Normal
NCT ID: NCT00045630 Org: User:
Start: 01/31/03 End: 12/31/11 Due: 12/31/12

S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00770224 Org: User:
Start: 04/30/09 End: 08/31/19 Due: 08/31/20

S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00088972 Org: User:
Start: 11/30/04 End: 07/31/09 Due: 07/31/10

Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02154490 Org: User:
Start: 07/08/14 End: 04/15/22 Due: 04/15/23

S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911

Phase: N/A Priority: Normal
NCT ID: NCT00896922 Org: User:
Start: 01/31/07 End: 10/31/09 Due: 10/31/10

Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02965378 Org: User:
Start: 10/31/14 End: 10/31/19 Due: 10/31/20

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00002657 Org: User:
Start: 05/31/95 End: 07/31/11 Due: 07/31/12

S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00053014 Org: User:
Start: 04/30/03 End: 06/30/06 Due: 06/30/07

S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma

Phase: N/A Priority: Normal
NCT ID: NCT00109889 Org: User:
Start: 04/30/05 End: 04/30/07 Due: 04/30/08

S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo

Phase: N/A Priority: Normal
NCT ID: NCT00775645 Org: User:
Start: 09/30/09 End: 06/30/13 Due: 06/30/14

S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract

Phase: N/A Priority: Normal
NCT ID: NCT00014144 Org: User:
Start: 02/28/01 End: 12/31/07 Due: 12/31/08

S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313

Phase: N/A Priority: Normal
NCT ID: NCT00949013 Org: User:
Start: 01/31/09 End: 04/30/09 Due: 04/30/10

S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01412879 Org: User:
Start: 11/30/11 End: 03/31/21 Due: 03/31/22

S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003549 Org: User:
Start: 10/31/98 End: 01/31/03 Due: 01/31/04

S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00040937 Org: User:
Start: 06/30/02 End: 10/31/15 Due: 10/31/16

S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00004217 Org: User:
Start: 02/29/00 End: 03/31/06 Due: 03/31/07

S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract

Phase: N/A Priority: Normal
NCT ID: NCT00022633 Org: User:
Start: 07/31/01 End: 07/31/11 Due: 07/31/12